Auteurs
Analysis
France
Racine
Analysis
France
Exploration
Accueil
Racine
Racine

Movement Disorders (revue) - Analysis (France)

Index « Auteurs » - entrée « Peter P. De Deyn »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Peter Lichtner < Peter P. De Deyn < Peter P. Pramstaller  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 2.
Ident.Authors (with country if any)Title
000314 (2007) Robert A. Hauser [États-Unis] ; Olivier Rascol [France] ; Amos D. Korczyn [Israël] ; A. Jon Stoessl [Canada] ; Ray L. Watts [États-Unis] ; Werner Poewe [Autriche] ; Peter P. De Deyn [Belgique] ; Anthony E. Lang [Canada]Ten‐year follow‐up of Parkinson's disease patients randomized to initial therapy with ropinirole or levodopa
000371 (2006) Olivier Rascol [France] ; David J. Brooks [Royaume-Uni] ; Amos D. Korczyn [Israël] ; Peter P. De Deyn [Belgique] ; Carl E. Clarke [Royaume-Uni] ; Anthony E. Lang [Canada] ; Mona Abdalla [Royaume-Uni]Development of dyskinesias in a 5‐year trial of ropinirole and L‐dopa

List of associated KwdEn.i

Nombre de
documents		Descripteur
2Antiparkinson Agents (adverse effects)
2Dyskinesia
2Humans
2Indoles (adverse effects)
2Levodopa
2Levodopa (adverse effects)
2Nervous system diseases
2Parkinson Disease (drug therapy)
2Parkinson disease
2Parkinson's disease
2Ropinirole
2dyskinesia
2levodopa
2ropinirole
1Aged
1Amantadine (adverse effects)
1Amantadine (therapeutic use)
1Antiparkinson Agents (therapeutic use)
1Complication
1Confidence Intervals
1Disability Evaluation
1Disease Progression
1Double-Blind Method
1Drug Therapy, Combination
1Dyskinesia, Drug-Induced (etiology)
1Dyskinesia, Drug-Induced (mortality)
1Female
1Follow-Up Studies
1Human
1Indoles (therapeutic use)
1Levodopa (therapeutic use)
1Longitudinal Studies
1Male
1Middle Aged
1Parkinson Disease (epidemiology)
1Parkinson Disease (mortality)
1Parkinson Disease (physiopathology)
1Predictive Value of Tests
1Proportional Hazards Models
1Risk Factors
1Survival Analysis
1Treatment
1Treatment Outcome
1dopamine agonist
1motor complications
1treatment
1wearing off

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/France/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i -k "Peter P. De Deyn" 

HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i  \
                -Sk "Peter P. De Deyn" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    France
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Peter P. De Deyn
}}
Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024